CA Patent

CA2644467C — Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent

Assigned to Les Laboratoires Servier SAS · Expires 2011-07-26 · 15y expired

What this patent protects

Forme cristalline .alpha. du composé de formule (I) caractérisée par son diagramme de diffraction X sur poudre. Médicaments.

USPTO Abstract

Forme cristalline .alpha. du composé de formule (I) caractérisée par son diagramme de diffraction X sur poudre. Médicaments.

Drugs covered by this patent

Patent Metadata

Patent number
CA2644467C
Jurisdiction
CA
Classification
—
Expires
2011-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Les Laboratoires Servier SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.